Oak Thistle LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.51M Buy
+22,013
New +$8.16M 0.82% 5
2025
Q4
Sell
-4,078
Closed -$1.32M 542
2025
Q3
$1.32M Buy
+4,078
New +$1.27M 0.2% 200
2024
Q4
Sell
-3,744
Closed -$1.95M 443
2024
Q3
$1.95M Buy
+3,744
New +$2M 0.63% 19
2024
Q1
Sell
-2,022
Closed -$953K 364
2023
Q4
$953K Sell
2,022
-3,351
-62% -$1.55M 0.27% 139
2023
Q3
$2.34M Buy
5,373
+3,109
+137% +$1.41M 0.69% 3
2023
Q2
$1.01M Buy
+2,264
New +$1.04M 0.53% 40
2022
Q3
Sell
-949
Closed -$458K 146
2022
Q2
$458K Buy
+949
New +$469K 0.88% 14

Other funds holding ELV

Oak Thistle LLC's ELV Position: Q2 2026 in Review

Oak Thistle LLC opened a new position in Elevance Health (ELV) in Q2 2026: 22,013 shares worth $8.51M. The stake represents 0.82% of the portfolio and ranks #5 among its holdings. This is a return to the name: Oak Thistle LLC previously reported a position in ELV as recently as Q3 2025.

Oak Thistle LLC first reported a position in ELV in Q2 2022 and has held it in 7 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Oak Thistle LLC held 22,013 shares of Elevance Health worth $8.51M as of Q2 2026.
  • Elevance Health was a new Oak Thistle LLC position in Q2 2026.
  • Elevance Health made up 0.82% of Oak Thistle LLC's portfolio in Q2 2026, its #5 holding.
  • Oak Thistle LLC first reported a position in Elevance Health in Q2 2022 and has held it in 7 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Oak Thistle LLC's 13F filing for Q2 2026, filed 21 Jul 2026.